Extended Data Fig. 5: Effect of tamoxifen and DCZ on tumor growth.
From: The GPCR–Gαs–PKA signaling axis promotes T cell dysfunction and cancer immunotherapy failure
Tumor growth curve of CD8-GsD littermate control mice implanted with 4MOSC1 tumors treated with or without tamoxifen or DCZ. Mice were given 3 doses of tamoxifen, and 5 × 105 4MOSC1 cells were implanted into the tongue. Where indicated, 0.01 mg/kg DCZ was administered daily starting one day after tumor implantation.
